(Q54264662)

27 May 2018

retracted paper

3 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

PubMed

https://github.com/jmillanacosta/retractable/blob/e28dcac33244e89948fe17fb65f09b59e2ed804d/data/PMIDS_DOIS.csv

title

Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer. (English)

1 reference

27 May 2018

author name string

Ying-Li Lin

1

1 reference

27 May 2018

Jian-Hua Ma

2

1 reference

27 May 2018

Xiang-Li Luo

3

1 reference

27 May 2018

Tong-Yu Guan

4

1 reference

27 May 2018

Zhi-Gang Li

5

1 reference

27 May 2018

publication date

23 January 2013

1 reference

27 May 2018

Journal of International Medical Research

published in

1 reference

27 May 2018

volume

41

1 reference

27 May 2018

issue

1

1 reference

27 May 2018

page(s)

48-54

1 reference

27 May 2018

Bladder cancer in 2010: how far have we come?

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Epigenetics of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Epigenetics of kidney cancer and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Epigenetics in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Non-clustered protocadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Guidelines on bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Declaration of Helsinki, 2008: implications for stakeholders in research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

DNA methylation and cancer diagnosis: new methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Promoter CpG island methylation markers in colorectal cancer: the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Cancer epigenomics: beyond genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Epigenetic markers of early tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Defining optimal therapy for muscle invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Biomarkers for bladder cancer aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513475571

21 January 2018

Identifiers

DOI

10.1177/0300060513475571

1 reference

27 May 2018

1 reference

27 May 2018